SCHEMBL4406527

SCHEMBL4406527

CC(C)c1ccc(C(C)(C)C[C@@H](C)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.44
HIF1A Q16665 2/20 0.44
CYP2D6 P10635 1/20 0.44
PTPN5 P54829 1/20 0.39
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
KIF11 P52732 1/20 0.36
HTT P42858 1/20 0.35
TYR P14679 1/20 0.35
SHBG P04278 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4399596 1.00 CYP2C9 (0.44) CYP2C9HIF1ACYP2D6PTPN5GRIN2D
SCHEMBL4406531 1.00 CYP2C9 (0.44) CYP2C9HIF1ACYP2D6PTPN5GRIN2D
SCHEMBL17275040 0.89 SHBG (0.41) CYP2C9HIF1AGRIN2DGRIN3BGRIN1
SCHEMBL4402677 0.82 TSHR (0.44) SHBG
SCHEMBL4402682 0.82 TSHR (0.44) SHBG
SCHEMBL4402678 0.82 TSHR (0.44) SHBG
SCHEMBL9887007 0.79 CYP2D6 (0.47) CYP2C9HIF1ACYP2D6PTPN5GRIN2D
SCHEMBL4399836 0.79 TAAR1 (0.50) HIF1ACYP2D6GRIN2DGRIN1GRIN2A
SCHEMBL4399833 0.79 TAAR1 (0.50) HIF1ACYP2D6GRIN2DGRIN1GRIN2A
SCHEMBL113841 0.79 TAAR1 (0.50) HIF1ACYP2D6GRIN2DGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427689-B1 4-METHYL-4-ARYL-2-PENTANOLS WITH AN ANTIMICROBIAL ACTION, PRODUCTION AND USE THEREOF SYMRISE GMBH & CO KG (DE) 2009-12-30 EP disclosed
US-7119123-B2 Antimicrobially active 4-methyl-4-aryl-2-pentanols, their preparation and use SYMRISE GMBH & CO. KG (DE) 2006-10-10 US disclosed
US-20040171698-A1 Antimicrobially active 4-methyl-4-aryl-2-pentanols, their preparation and use SYMRISE AG (DE) 2004-09-02 US disclosed
EP-1427689-A1 4-METHYL-4-ARYL-2-PENTANOLS WITH AN ANTIMICROBIAL ACTION, PRODUCTION AND USE THEREOF Symrise GmbH & Co. KG (DE) 2004-06-16 EP disclosed
WO-2003024907-A1 4-METHYL-4-ARYL-2-PENTANOLS WITH AN ANTIMICROBIAL ACTION, PRODUCTION AND USE THEREOF SYMRISE GMBH & CO. KG (DE) 2003-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171698-A1 Antimicrobially active 4-methyl-4-aryl-2-pentanols, their preparation and use SRD5A2, HSD3B1, HSD17B2 CYP2C9 819/4885HIF1A 1570/4885CYP2D6 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.